{"id":"blood-sampling-for-pharmacokinetics","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"This is not a drug itself, but rather a diagnostic procedure used during clinical trials to characterize how a drug is processed by the body. Pharmacokinetic sampling involves collecting blood samples at predetermined timepoints to measure plasma or serum drug concentrations, which are then analyzed to determine key parameters such as bioavailability, half-life, clearance, and volume of distribution.","oneSentence":"Blood sampling for pharmacokinetics is a clinical procedure to measure drug concentrations in blood over time to assess absorption, distribution, and elimination.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:58:30.267Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00001309","phase":"PHASE1","title":"The Body's Affect on Vitamin C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1997-01-23","conditions":"Healthy Volunteers","enrollment":23},{"nctId":"NCT07322406","phase":"NA","title":"Kaempferol Absorption and Pharmacokinetics Evaluation","status":"RECRUITING","sponsor":"University of Pittsburgh","startDate":"2025-12-09","conditions":"No Disease, Mitochondria Health, Longevity","enrollment":120},{"nctId":"NCT05524311","phase":"PHASE2","title":"Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-10","conditions":"Juvenile Dermatomyositis","enrollment":16},{"nctId":"NCT06963216","phase":"PHASE3","title":"A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis","status":"RECRUITING","sponsor":"Kedrion S.p.A.","startDate":"2026-02","conditions":"Acquired Factor X Deficiency","enrollment":15},{"nctId":"NCT07436858","phase":"PHASE1","title":"Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2026-08-01","conditions":"Lung Cancer (NSCLC), HER2 Expression, HER2 Gene Mutation","enrollment":20},{"nctId":"NCT03830320","phase":"PHASE1","title":"Positron Emission Tomography (PET) Imaging of Thrombosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2016-04-01","conditions":"Atrial Fibrillation, COVID-19, Cancer","enrollment":165},{"nctId":"NCT06492122","phase":"PHASE1","title":"Study With [225Ac]Ac-FL-020 in mCRPC Participants","status":"RECRUITING","sponsor":"Full-Life Technologies GmbH","startDate":"2024-08-30","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT06939608","phase":"NA","title":"Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2025-04-28","conditions":"Pharmacokinetic Study in Healthy Volunteers","enrollment":36},{"nctId":"NCT07084129","phase":"PHASE1","title":"Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-04","conditions":"Sepsis","enrollment":20},{"nctId":"NCT04868188","phase":"","title":"Pharmacokinetics of Voriconazole in Adult ECMO Patients","status":"COMPLETED","sponsor":"University Hospitals, Leicester","startDate":"2021-08-10","conditions":"Aspergillosis, Influenza, Covid19","enrollment":32},{"nctId":"NCT06119061","phase":"PHASE4","title":"Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage","status":"RECRUITING","sponsor":"Aaron Cook","startDate":"2024-07-02","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":20},{"nctId":"NCT06093269","phase":"PHASE4","title":"Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2023-11-20","conditions":"Hemodialysis Catheter Infection, Infection, Bacterial","enrollment":32},{"nctId":"NCT02197234","phase":"PHASE1","title":"Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-12-22","conditions":"Non Small Cell Lung Cancer","enrollment":52},{"nctId":"NCT05687500","phase":"PHASE2","title":"Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-20","conditions":"Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction","enrollment":35},{"nctId":"NCT02157883","phase":"PHASE1","title":"Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-06","conditions":"Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer","enrollment":39},{"nctId":"NCT05055830","phase":"","title":"Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)","status":"RECRUITING","sponsor":"Duke University","startDate":"2021-10-05","conditions":"Cardiac Disease, Critically Ill, Children, Adult","enrollment":2000},{"nctId":"NCT01697930","phase":"PHASE1","title":"A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-09","conditions":"Solid Malignancy, Lymphoma","enrollment":67},{"nctId":"NCT07045467","phase":"PHASE1","title":"Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-07-01","conditions":"Chronic Kidney Diseases, Renal Transplantation","enrollment":30},{"nctId":"NCT05495932","phase":"NA","title":"Mepolizumab Pharmacokinetics Among Patients With Severe Asthma","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2022-11-15","conditions":"Asthma","enrollment":50},{"nctId":"NCT06431984","phase":"NA","title":"Pharmacology Space Kit (PSK) - Dried Blood Spot for Caffeine Pharmacokinetics Under Microgravity Conditions","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2023-03-27","conditions":"Drug Mechanism, Metabolism Medication Toxicity, Space Motion Sickness","enrollment":30},{"nctId":"NCT06263582","phase":"PHASE1","title":"Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2024-05-29","conditions":"Cervix Cancer, Cervix Intraepithelial Neoplasia Grade 3, Cervix; Intraepithelial Neoplasia, Grade I","enrollment":12},{"nctId":"NCT05020275","phase":"","title":"Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rennes University Hospital","startDate":"2021-12-29","conditions":"Lung Cancer","enrollment":60},{"nctId":"NCT07114627","phase":"","title":"Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2025-02-18","conditions":"Solid Cancer, Gastric (Cardia, Body) Cancer, Esophageal Cancer","enrollment":66},{"nctId":"NCT05861258","phase":"PHASE2","title":"Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2023-05-08","conditions":"Mycobacterium Avium Complex Pulmonary Disease","enrollment":12},{"nctId":"NCT04887467","phase":"PHASE4","title":"Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2021-09-16","conditions":"Parkinson Disease","enrollment":19},{"nctId":"NCT04036500","phase":"EARLY_PHASE1","title":"Transgender Estradiol","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2019-09-23","conditions":"Transgender Persons","enrollment":11},{"nctId":"NCT05259553","phase":"NA","title":"Biomarkers in Multiple Myeloma","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-05-20","conditions":"Hematological Patients, Newly Diagnosed Multiple Myeloma, Chemotherapy","enrollment":70},{"nctId":"NCT05443087","phase":"NA","title":"TARGETed Therapy Drug MONITOring in DIGestive Oncology","status":"RECRUITING","sponsor":"UNICANCER","startDate":"2022-08-29","conditions":"Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma","enrollment":330},{"nctId":"NCT02348749","phase":"PHASE1, PHASE2","title":"18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-01","conditions":"Neuroendocrine Tumors","enrollment":48},{"nctId":"NCT03723772","phase":"PHASE1","title":"A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-11-29","conditions":"Diabetes Mellitus, Type 1","enrollment":66},{"nctId":"NCT06857292","phase":"PHASE2","title":"Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-12-01","conditions":"Chemotherapy-Induced Neutropenia","enrollment":97},{"nctId":"NCT03717623","phase":"PHASE4","title":"Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants","status":"RECRUITING","sponsor":"Melbourne Health","startDate":"2019-08-01","conditions":"Posaconazole, Pharmacokinetics, Invasive Candidiases","enrollment":100},{"nctId":"NCT06699901","phase":"","title":"Antibiotic Concentrations After MassivE Transfusion Study","status":"RECRUITING","sponsor":"Brooke Army Medical Center","startDate":"2024-09-30","conditions":"Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents","enrollment":417},{"nctId":"NCT05698771","phase":"PHASE1","title":"NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2022-09-17","conditions":"Healthy","enrollment":12},{"nctId":"NCT04489134","phase":"PHASE2","title":"P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2022-02-15","conditions":"Pharmacokinetics","enrollment":27},{"nctId":"NCT02023996","phase":"NA","title":"PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-12","conditions":"Esophagogastric Cancer","enrollment":42},{"nctId":"NCT05490732","phase":"NA","title":"Pharmacokinetic Modeling of Methadone","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-03-23","conditions":"Toxicomania","enrollment":100},{"nctId":"NCT04436991","phase":"","title":"Antibiotic Dosing in Geriatric Patients At the Emergency Department","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2018-01-03","conditions":"Elderly Infection, Frailty, Frail Elderly Syndrome","enrollment":180},{"nctId":"NCT04163016","phase":"PHASE1","title":"A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2020-06-19","conditions":"Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease","enrollment":22},{"nctId":"NCT06247748","phase":"PHASE1","title":"Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects","status":"COMPLETED","sponsor":"Beijing Dongfang Biotech Co., Ltd.","startDate":"2023-10-19","conditions":"Diabetes Mellitus, Type 2, Overweight","enrollment":28},{"nctId":"NCT01420562","phase":"","title":"Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2011-09","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","enrollment":55},{"nctId":"NCT04214587","phase":"","title":"Biological Investigation of Explanted Endobronchial Lung Valves Study","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2021-03-16","conditions":"Emphysema or COPD","enrollment":150},{"nctId":"NCT03542812","phase":"EARLY_PHASE1","title":"L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia","status":"TERMINATED","sponsor":"University of Utah","startDate":"2019-07-30","conditions":"Infant,Premature, Bronchopulmonary Dysplasia, Pulmonary Hypertension","enrollment":16},{"nctId":"NCT05136963","phase":"PHASE1","title":"Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2024-06","conditions":"Kidney Function Test","enrollment":48},{"nctId":"NCT05245734","phase":"PHASE4","title":"Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women","status":"RECRUITING","sponsor":"Biopharma Plasma LLC","startDate":"2022-02-08","conditions":"Pregnancy Related","enrollment":281},{"nctId":"NCT06342505","phase":"","title":"Tacrolimus in CD3+ T Lymphocytes","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2022-05-30","conditions":"Immunosuppression","enrollment":28},{"nctId":"NCT02163733","phase":"PHASE1","title":"Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-14","conditions":"Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer","enrollment":38},{"nctId":"NCT01886404","phase":"","title":"EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2013-12-01","conditions":"HIV Infection","enrollment":30},{"nctId":"NCT04258475","phase":"PHASE4","title":"The Influence of Concurrent Oral Calcium Carbonate Supplementation on Steady State Pharmacokinetics of Oral Raltegravir.","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2020-12-09","conditions":"Calcium Supplementation in HIV Patients Using Raltegravir","enrollment":12},{"nctId":"NCT04331288","phase":"PHASE1","title":"Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)","status":"COMPLETED","sponsor":"Pop Test Oncology LLC","startDate":"2021-11-01","conditions":"Potential Treatment for Alcohol Dependence-Alcohol Interaction","enrollment":10},{"nctId":"NCT03399032","phase":"","title":"Pharmacokinetics of Caspofungin","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2018-02-05","conditions":"Septic Shock, Fungal Infection, Critical Illness","enrollment":33},{"nctId":"NCT01099644","phase":"PHASE1","title":"Intraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum","status":"TERMINATED","sponsor":"Y-mAbs Therapeutics","startDate":"2010-04","conditions":"Peritoneal Cancer","enrollment":54},{"nctId":"NCT04621604","phase":"NA","title":"Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.","status":"TERMINATED","sponsor":"Rennes University Hospital","startDate":"2021-04-12","conditions":"Hodgkin Lymphoma","enrollment":7},{"nctId":"NCT04335370","phase":"","title":"Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2019-01-09","conditions":"Cystic Fibrosis, Polymyxin B","enrollment":9},{"nctId":"NCT05074550","phase":"PHASE1","title":"Safety Evaluation Study for Patients With Polycythemia Vera","status":"UNKNOWN","sponsor":"Perseus Proteomics Inc.","startDate":"2022-08-24","conditions":"Polycythemia Vera","enrollment":6},{"nctId":"NCT02484677","phase":"PHASE4","title":"Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2015-07-15","conditions":"Patients With Head and Neck Cancer (ORL)","enrollment":12},{"nctId":"NCT05056584","phase":"NA","title":"The Role of the Kidneys and Liver in the Elimination of Glucagon","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2020-08-01","conditions":"Chronic Kidney Diseases, Liver Cirrhosis, Hyperglucagonemia","enrollment":48},{"nctId":"NCT05199610","phase":"PHASE1","title":"An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143","status":"COMPLETED","sponsor":"EQRx International, Inc.","startDate":"2022-03-30","conditions":"Severe Hepatic Impairment","enrollment":12},{"nctId":"NCT01709136","phase":"PHASE2, PHASE3","title":"Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2005-12","conditions":"Hypertension","enrollment":3},{"nctId":"NCT04915872","phase":"","title":"Are Standard Dosing Regimens of Piperacillin-Tazobactam Suitable in Critically Ill Patients With Open Abdomen and Negative Pressure Wound Therapy? A Population Pharmacokinetic Study.","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-07-01","conditions":"Laparotomy, Critical Illness, Piperacillin, Tazobactam Drug Combination","enrollment":46},{"nctId":"NCT04868786","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-10-26","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":20},{"nctId":"NCT02973750","phase":"","title":"Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2016-10-20","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":20},{"nctId":"NCT05251376","phase":"PHASE1","title":"Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy","status":"WITHDRAWN","sponsor":"Lyndra Inc.","startDate":"2022-02-28","conditions":"Opioid Use Disorder, Moderate","enrollment":""},{"nctId":"NCT04592016","phase":"NA","title":"Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects","status":"COMPLETED","sponsor":"Joanneum Research Forschungsgesellschaft mbH","startDate":"2020-10-08","conditions":"Healthy","enrollment":22},{"nctId":"NCT04079257","phase":"","title":"The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2021-02-23","conditions":"Paroxysmal Nocturnal Hemoglobinuria, Eculizumab, PK-PD","enrollment":27},{"nctId":"NCT04200066","phase":"PHASE1","title":"A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma","status":"WITHDRAWN","sponsor":"University of Rochester","startDate":"2022-06-01","conditions":"Glioblastoma, Brain Tumor","enrollment":""},{"nctId":"NCT03092037","phase":"","title":"Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-03-23","conditions":"Contraception","enrollment":900},{"nctId":"NCT05446090","phase":"","title":"Asthma: Phenotyping Exacerbations 3","status":"UNKNOWN","sponsor":"University of Nottingham","startDate":"2022-05-09","conditions":"Asthma Attack","enrollment":100},{"nctId":"NCT05406492","phase":"","title":"Population PK of Antibiotics, Sedative and Analgesics, and Antiplatelet Drugs During ECMO","status":"UNKNOWN","sponsor":"Gachon University Gil Medical Center","startDate":"2019-07-16","conditions":"Pharmacokinetics, Extracorporeal Membrane Oxygenation","enrollment":10},{"nctId":"NCT00715988","phase":"PHASE1","title":"Methadone Pharmacokinetics and Cardiac Effects in Newborns","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-10","conditions":"Pain","enrollment":7},{"nctId":"NCT05241561","phase":"PHASE2","title":"Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2022-06","conditions":"Cancer of Kidney","enrollment":24},{"nctId":"NCT02260102","phase":"PHASE4","title":"Temocillin Pharmacokinetics in Paediatrics","status":"UNKNOWN","sponsor":"Université Catholique de Louvain","startDate":"2016-02-17","conditions":"Infection, Liver Dysfunction, Urinary Tract Infection","enrollment":45},{"nctId":"NCT03440216","phase":"NA","title":"Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units","status":"UNKNOWN","sponsor":"Université Catholique de Louvain","startDate":"2018-03-15","conditions":"Pharmacokinetics, Anti-Bacterial Agents, Infection, Bacterial","enrollment":20},{"nctId":"NCT05324917","phase":"","title":"Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2022-04-10","conditions":"Rituximab, Children, Blood Disease","enrollment":20},{"nctId":"NCT03571802","phase":"PHASE4","title":"Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2018-06-13","conditions":"Obesity, Hyperlipidemias","enrollment":10},{"nctId":"NCT04049786","phase":"PHASE4","title":"Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol","status":"UNKNOWN","sponsor":"Natalia Valadares de Moraes","startDate":"2019-06-01","conditions":"Obesity, Bariatric Surgery, Roux-en Y Gastric Bypass","enrollment":120},{"nctId":"NCT04625764","phase":"NA","title":"Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery","status":"TERMINATED","sponsor":"CytoSorbents Europe GmbH","startDate":"2021-02-23","conditions":"Acute Coronary Syndrome","enrollment":6},{"nctId":"NCT02960568","phase":"PHASE1","title":"Genetic Variability in CYP2D6 in U.S Active Duty Population","status":"COMPLETED","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2016-01-08","conditions":"Pharmacologic Action","enrollment":550},{"nctId":"NCT02588287","phase":"NA","title":"Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-11","conditions":"Hepatitis C and HIV Coinfection","enrollment":14},{"nctId":"NCT03665155","phase":"PHASE1, PHASE2","title":"First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-09-05","conditions":"Multiple Myeloma","enrollment":11},{"nctId":"NCT02197247","phase":"PHASE1","title":"Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-12-04","conditions":"Non Small Cell Lung Cancer","enrollment":41},{"nctId":"NCT04945954","phase":"NA","title":"Pharmacokinetic Study of Post-transplant Cyclophosphamide in Pediatric Patients","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2021-06","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":15},{"nctId":"NCT00776555","phase":"PHASE1","title":"Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution","status":"TERMINATED","sponsor":"Shire","startDate":"2008-11-21","conditions":"Healthy","enrollment":3},{"nctId":"NCT02216084","phase":"PHASE1","title":"Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2014-09-30","conditions":"Hereditary Thrombotic Thrombocytopenic Purpura (TTP)","enrollment":16},{"nctId":"NCT04349696","phase":"PHASE4","title":"Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)","status":"COMPLETED","sponsor":"Orient Europharma Co., Ltd.","startDate":"2014-02-11","conditions":"Type 2 Diabetes Mellitus, Liver Dysfunction","enrollment":16},{"nctId":"NCT04863144","phase":"","title":"Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-08-01","conditions":"Liver Diseases","enrollment":40},{"nctId":"NCT03766854","phase":"PHASE1","title":"A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-12-07","conditions":"Diabetes Mellitus, Type 1","enrollment":24},{"nctId":"NCT03126370","phase":"PHASE4","title":"Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-01-08","conditions":"Hepatitis C, HIV Coinfection","enrollment":10},{"nctId":"NCT02824159","phase":"","title":"Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-04","conditions":"Hematological Malignancies","enrollment":121},{"nctId":"NCT04673396","phase":"PHASE1","title":"Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor","status":"UNKNOWN","sponsor":"Beijing Nuokangda Pharmaceutical Technology Co., Ltd.","startDate":"2020-09-22","conditions":"Solid Tumor","enrollment":36},{"nctId":"NCT01027364","phase":"PHASE3","title":"Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B","status":"COMPLETED","sponsor":"Bioverativ Therapeutics Inc.","startDate":"2009-12","conditions":"Severe Hemophilia B","enrollment":123},{"nctId":"NCT03197961","phase":"EARLY_PHASE1","title":"Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP","status":"COMPLETED","sponsor":"Sharon Achilles","startDate":"2017-11-17","conditions":"HIV/AIDS, Contraception","enrollment":15},{"nctId":"NCT03714789","phase":"","title":"Clearance and Pharmacokinetics of Antibiotics in Renal Replacement Therapy","status":"COMPLETED","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2017-11-01","conditions":"Kidney Failure","enrollment":19},{"nctId":"NCT03669965","phase":"PHASE2","title":"KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera","status":"UNKNOWN","sponsor":"Kartos Therapeutics, Inc.","startDate":"2019-01-15","conditions":"Polycythemia Vera","enrollment":20},{"nctId":"NCT03401541","phase":"EARLY_PHASE1","title":"25-Hydroxyvitamin D Pharmacokinetic Study","status":"COMPLETED","sponsor":"Boston University","startDate":"2018-10-01","conditions":"Vitamin D Deficiency, Fat Malabsorption","enrollment":16},{"nctId":"NCT03035578","phase":"PHASE1, PHASE2","title":"Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population","status":"WITHDRAWN","sponsor":"The Hospital for Sick Children","startDate":"2017-12-01","conditions":"Pain, Drug Effect","enrollment":""},{"nctId":"NCT04121910","phase":"PHASE1","title":"A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-11-07","conditions":"Solid Tumour","enrollment":16},{"nctId":"NCT04083443","phase":"","title":"Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility","status":"UNKNOWN","sponsor":"University of Cologne","startDate":"2019-07-23","conditions":"Blood Stream Infections","enrollment":120},{"nctId":"NCT02581280","phase":"","title":"Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-12","conditions":"Cardiac Dysfunction","enrollment":56},{"nctId":"NCT02295488","phase":"NA","title":"Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-03-23","conditions":"Hymenoptera Allergy","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2621,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Blood sampling for pharmacokinetics","genericName":"Blood sampling for pharmacokinetics","companyName":"Erasmus Medical Center","companyId":"erasmus-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}